Could this Healthcare Stock really climb 129.26% in 2023?

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [The $193 Billion US-China War You Don't Know About]( [See How the US-China "Lithium War" Is Creating Huge Investment Opportunities]( --------------------------------------------------------------- June 29, 2023 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [Soaring EV Industry Keeps Investor Focus on Lithium]( need for lithium keeps going up, up, up with the mass adoption of electric vehicles. The lithium demand for EV batteries alone is now double the rate of lithium production. That's why the U.S. government is pulling out all the stops to encourage domestic lithium production. [See Who Could Benefit From "Mined in America" Lithium]( --------------------------------------------------------------- [Constellation Brands]( Symbol: [STZ]( Recent Price: $246.78 Average Analyst Price Target: $265.22 (9.53%) Market Cap: $45.26B Last Year's EPS: $2.83 Consensus EPS Forecast: $1.82 Expected Earnings Date: Jun 30 2023 Recent Analyst Action: Gerald Pascarelli, analyst at Wedbush, reiterates coverage on [Constellation Brands (STZ)]( in the Consumer Defensive sector with a Buy rating and a price target of $270 (1 day ago). [TipRanks.com]( also reports that [Constellation Brands]( currently has 20 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $265.22 . The target pricing ranges from a high forecast of $305.00 down to a low forecast of $200.00. [Constellation Brands (STZ)](’s last closing price was $246.78 which would put the average price target at 9.53% upside. Here are 3rd party ratings for [STZ](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 28% (70 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [WARNING: These 110 Banks Are Planning to Replace the U.S. Dollar]( pay close attention because if your bank is on [this “blacklist” with 110 banks,]( your entire life savings could be at risk. According to this famous banker, you must move your cash before July 26… Or risk losing everything. [Click here to get the details and learn how to prepare]( for what The Wall Street Journal called a “game-changing development.” [PREPARE NOW.]( --------------------------------------------------------------- [Gerresheimer]( Symbol: [GRRMF]( Recent Price: $96.30 Average Analyst Price Target: $131.65 (36.71%) Market Cap: $3.45B Last Year's EPS: $1.15 Consensus EPS Forecast: $1.47 Expected Earnings Date: Jul 06 2023 Recent Analyst Action: Christoph Gretler, analyst at Credit Suisse, reiterates coverage on [Gerresheimer (GRRMF)]( in the Industrials sector with a Buy rating and a price target of $120.41 (16 hours ago). [TipRanks.com]( also reports that [Gerresheimer]( currently has 6 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $131.65. The target pricing ranges from a high forecast of $157.74 down to a low forecast of $107.82. [Gerresheimer (GRRMF)](’s last closing price was $96.30 which would put the average price target at 36.71% upside. Here are 3rd party ratings for [GRRMF](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: n/a - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Hate losing money? Try this]( If you’re tired of holding your breath every time you open your trading account… only to see red. If you’re done shouldering the stress that comes from knowing there’s really no easy solution to the financial mess America is in… and if you’re finally ready to consider a common-sense approach to making money… one that could let you rake in massive winners of 96%...100%...and even 203%... FAST (even in today’s topsy-turvy market)... [You’re going to love what I’m about to show you here.]( --------------------------------------------------------------- [KalVista Pharmaceuticals]( Symbol: [KALV]( Recent Price: $9.16 Average Analyst Price Target: $38.00 (129.26%) Market Cap: $303.42M Last Year's EPS: -$0.9 Consensus EPS Forecast: -$0.98 Expected Earnings Date: Jul 06 2023 Recent Analyst Action: Joseph Schwartz, analyst at SVB Securities, reiterates coverage on [KalVista Pharmaceuticals (KALV)]( in the Healthcare sector with a Buy rating and a price target of $20 (1 month ago). [TipRanks.com]( also reports that [KalVista Pharmaceuticals]( currently has 15 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $38.00 . The target pricing ranges from a high forecast of $38.00 down to a low forecast of $38.00. [KalVista Pharmaceuticals (KALV)](’s last closing price was $9.16 which would put the average price target at 129.26% upside. Here are 3rd party ratings for [KALV](: - TipRanks.com: Moderate Buy - TradingView.com: Neutral - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 41% (104 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Kura Sushi USA]( Symbol: [KRUS]( Recent Price: $90.66 Average Analyst Price Target: $53.00 (-12.03%) Market Cap: $975.89M Last Year's EPS: -$0.21 Consensus EPS Forecast: -$0.22 Expected Earnings Date: Jul 06 2023 Recent Analyst Action: Jon Tower, analyst at Citi, reiterates coverage on [Kura Sushi USA (KRUS)]( in the Consumer Cyclical sector with a Hold rating and a price target of $88 (3 weeks ago). [TipRanks.com]( also reports that [Kura Sushi USA]( currently has 14 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $53.00 . The target pricing ranges from a high forecast of $53.00 down to a low forecast of $53.00. [Kura Sushi USA (KRUS)](’s last closing price was $90.66 which would put the average price target at -12.03% upside. Here are 3rd party ratings for [KRUS](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 12% (31 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The "Amazon Secret Royalty Program" Can Help Anyone Retire Like Royalty]( unique type of investment could help you make more money than you will need for the rest of your life. It’s what we call the “Amazon secret royalty program.” It’s an income stream that allows you to collect $1,000s… $10,000s… or more every year! In fact, Business Insider says this type of investment could provide “enough money to live off of each year, without having any other retirement plan...” “Royalties” are the most exciting investments in history. Put simply, they’re periodic payouts… That could deliver all the money you need for your retirement… While these “royalties” are different from traditional royalties, just one could hand you enough income to live life on your own terms. And it only takes a few minutes to set up. [Learn how to collect your first payout before September 10th.]( --------------------------------------------------------------- [Levi Strauss & Co]( Symbol: [LEVI]( Recent Price: $14.34 Average Analyst Price Target: $23.67 (26.43%) Market Cap: $5.77B Last Year's EPS: $0.34 Consensus EPS Forecast: $0.32 Expected Earnings Date: Jul 06 2023 Recent Analyst Action: Drew Crum, analyst at Stifel Nicolaus, reiterates coverage on [Levi Strauss & Co (LEVI)]( in the Consumer Cyclical sector with a Buy rating and a price target of $19 (2 months ago). [TipRanks.com]( also reports that [Levi Strauss & Co]( currently has 13 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $23.67 . The target pricing ranges from a high forecast of $36.00 down to a low forecast of $17.00. [Levi Strauss & Co (LEVI)](’s last closing price was $14.34 which would put the average price target at 26.43% upside. Here are 3rd party ratings for [LEVI](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Bottom 24% (192 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Simulations Plus]( Symbol: [SLP]( Recent Price: $43.22 Average Analyst Price Target: $67.00 (48.08%) Market Cap: $875.65M Last Year's EPS: $0.06 Consensus EPS Forecast: $0.18 Expected Earnings Date: Jul 06 2023 Recent Analyst Action: Matt Hewitt, analyst at Craig-Hallum, reiterates coverage on [Simulations Plus (SLP)]( in the Healthcare sector with a Buy rating (1 week ago). [TipRanks.com]( also reports that [Simulations Plus]( currently has 14 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $67.00 . The target pricing ranges from a high forecast of $67.00 down to a low forecast of $67.00. [Simulations Plus (SLP)](’s last closing price was $43.22 which would put the average price target at 48.08% upside. Here are 3rd party ratings for [SLP](: - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 38% (95 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [All Electric Commitment From GM, Volkswagen, Could Put Lithium Sector In A Supercycle]( automakers are pledging to go "fully electric" by 2035. NOW is the perfect time to get in on the "EV Revolution." And the best way to potentially do that, is to skip over the overvalued electric vehicle stocks... [See how EV demand could create new lithium investment opportunities]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software